Impact of an Antimicrobial Stewardship Program on Pre-Therapy Pathogen Detection Specimen Submission, Antimicrobial Use, and Resistant Pathogens: An Interrupted Time Series Analysis

抗菌药物管理计划对治疗前病原体检测标本提交、抗菌药物使用和耐药病原体的影响:一项中断时间序列分析

阅读:2

Abstract

BACKGROUND: Inappropriate antibiotic use drives antimicrobial resistance (AMR). Performing pathogen detection before initiating antimicrobial therapy is essential for antimicrobial stewardship (AMS), enabling targeted treatment. Robust evidence on multifaceted interventions' sustained impact on pre-therapy pathogen detection specimen submission rates, AMS metrics, and multidrug-resistant organisms (MDROs) is limited. METHODS: Interrupted time series analysis evaluated a comprehensive AMS intervention (April 2023) at a tertiary care hospital in China (April 2022-May 2025). Interventions included: team establishment, lab expansion, education, electronic restrictions for restricted/special use-levels antibiotics (mandating pre-therapy pathogen detection specimen submission rate), audit/feedback, and monitoring. Segmented regression assessed level (immediate) and slope (trend) changes in pre-therapy pathogen detection specimen submission rate, antimicrobial use, costs, and MDRO isolate rates. RESULTS: Post-intervention, overall pre-therapy pathogen detection specimen submission rate increased immediately (+9.82%, P=0.009) with sustained monthly growth (+1.21%, P<0.001); increases occurred across all antimicrobial classes (all P<0.05). Antimicrobial use intensity reversed significantly from a pre-intervention upward trend (β(1) = +1.22 DDDs/100PD, P=0.002) to a sustained downward trajectory (β(3) = -1.36, P=0.001), with non-restricted agents showing the steepest decline (net slope = -0.16). Concurrently, antimicrobial utilization rate, per capita costs, and cost proportion reversed to downward trends (all P<0.05), while testing costs remained stable Only carbapenem-resistant Klebsiella pneumoniae (CRKP) exhibited sustained reduction (-0.87%/month, P=0.013); other MDROs showed no significant changes. CONCLUSION: The intervention significantly improved pre-therapy pathogen detection specimen submission rate and optimized antimicrobial use (reduced intensity/costs), but demonstrated limited resistance impact beyond CRKP reduction. Sustainable AMR control requires integrating diagnostic stewardship with infection prevention programs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。